Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Payables (2016 - 2017)

Bone Biologics has reported Payables over the past 3 years, most recently at $216903.0 for Q4 2017.

  • Quarterly Payables fell 85.15% to $216903.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $216903.0 through Dec 2017, down 85.15% year-over-year, with the annual reading at $216903.0 for FY2017, 85.15% down from the prior year.
  • Payables was $216903.0 for Q4 2017 at Bone Biologics, down from $3.6 million in the prior quarter.
  • Over five years, Payables peaked at $3.6 million in Q3 2017 and troughed at -$211265.0 in Q4 2015.
  • The 3-year median for Payables is $484014.0 (2016), against an average of $1.2 million.
  • The largest YoY upside for Payables was 980.96% in 2017 against a maximum downside of 85.15% in 2017.
  • A 3-year view of Payables shows it stood at -$211265.0 in 2015, then surged by 791.15% to $1.5 million in 2016, then tumbled by 85.15% to $216903.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Payables are $216903.0 (Q4 2017), $3.6 million (Q3 2017), and $2.5 million (Q2 2017).